SEC Form 4 · accession 0001127602-19-002783
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Felicia Williams
Director
Period of report
Jan 24, 2019
Accepted (ET)
Jan 28, 2019 · 11:28 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 24, 2019 | A | 981 | $0.00 | A | 981 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $16.97 | Jan 24, 2019 | A | 8,740 | A | — | Jan 24, 2029 | Common Stock | 8,740 | 8,740 | D |
Explanation of responses
- F1These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest 25% every 90 days from the date of grant.
- F2These options are awarded under the 2012 Stock Incentive Plan and vest 25% every 90 days from the date of grant.